Results 41 to 48 of about 712 (48)

Development and Evaluation of Gastroretentive Atenolol Tablets

Zagazig Journal of Pharmaceutical Sciences, 2014
The low oral bioavailability of atenolol is primarily because of its poor absorption from the lower gastrointestinal tract. Gastroretentive dosage forms provide an opportunity to deliver the drug with absorption window in the proximal part of the GIT ...
Rachna kumria , Dileep Kumar Reddy , Vikas Bansal , Anroop B. Nair , Azza A. Hasan   +4 more
doaj   +1 more source

A meta-analytical comparison of atenolol with angiotensin-converting enzyme inhibitors on arterial stiffness, peripheral blood pressure and heart rate in hypertensive patients

Clinical and Experimental Hypertension, 2017
Objectives: This meta-analysis of randomized parallel controlled trials was designed to compare the efficacy of atenolol with angiotensin-converting enzyme inhibitors (ACEIs) in changing pulse wave velocity (PWV), peripheral blood pressure and heart rate
Hong Xie, Gaoqing Luo, Yong Zheng, Feng Peng, Liangdi Xie   +4 more
doaj   +1 more source

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1

BJUI Compass
Objectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic ...
Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts   +12 more
doaj   +1 more source

Synthesis of Atenolol-Imprinted Polymers with Methyl Methacrylate as Functional Monomer in Propanol Using Bulk and Precipitation Polymerization Method

Journal of Analytical Methods in Chemistry, 2019
Atenolol is one of the beta-1 blocker drugs that is misused by athletes to increase their performance during competition. Therefore, it is important to analyze atenolol levels in blood selectively.
Aliya Nur Hasanah, Traju Ningtias Dwi Utari, Rimadani Pratiwi   +2 more
doaj   +1 more source

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study

Кардиоваскулярная терапия и профилактика, 1970
Aim. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that used non ...
Kl. O. Stumpe, E. Agabiti-Rosei, T. Zielinski, D. Schremmer, J. Scholze, P. Laeis, P. Schwandt, M. Ludwig   +7 more
doaj  

Electrochemical sensing of atenolol using silver-reduced graphene oxide carbon paste nanocomposite electrode

Journal of Electrochemical Science and Engineering
Atenolol, one of the most prescribed β₁-selective adrenergic blockers, has been increasingly detected in aquatic ecosystems due to incomplete elimination in sewage treatment plants, posing an ecotoxicological hazard to the environment.
Nevila Broli, Sadik Cenolli, Loreta Vallja, Majlinda Vasjari, Ana Ameda, Lueda Kulla   +5 more
doaj   +1 more source

ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY

Российский кардиологический журнал, 2011
We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade.
H. Yokoyama, D. B. Averill, K. B. Brosnihan, R. D. Smith, E. L. Schiffrin, C. M. Ferrario   +5 more
doaj